The Origin and Stimuli Implicated in the Expression of Nestin(+) Cardiac Myocyte-like Cells in the Ischemic Heart by Assimakopoulos, John
University of Montreal 
 
 
 
The Origin and Stimuli Implicated in the 
Expression of Nestin(+) Cardiac Myocyte-
like Cells in the Ischemic Heart 
 
 
 
 
 
 
By 
John Assimakopoulos 
 
 
 
 
 
 
Department of Physiology 
Faculty of Medicine 
University of Montreal 
 
 
 
 
Memoir presented to the Faculty of Superior Studies 
In light of obtaining the grade of 
M.Sc. in Physiology 
 
 
 
 
January 2009 
 
 
 
©, John Assimakopoulos, 2009 
 
 ii 
 
 
 
University of Montreal 
Faculty of Superior Studies 
 
 
 
 
 
Memoir Title: 
 
 
 
The Origin and Stimuli Implicated in the Expression 
of Nestin(+) Cardiac Myocyte-like Cells in the Ischemic Heart 
 
 
 
 
 
Presented by:  John Assimakopoulos 
 
 
 
was evaluated by a jury composed of the following members: 
 
 
 
 
Dr Angelino Calderone 
Research Director 
 
 
Dr Jocelyn Dupuis 
President Reporter 
 
 
Dr Madhu Anand-Srivastava 
Jury Member 
 
 
 
 iii 
Abstract 
 
Studies from our lab demonstrated that scar formation and healing was 
associated with the appearance of nestin(+) cardiac myocyte-like cells predominantly 
at the peri-infarct region.  The focus of the present study was to identify the 
underlying mechanism(s) (e.g. hypoxia, neurohormones) implicated in their 
recruitment and their cellular origin.  The presence of these cells was detected as 
early as 1-week post-myocardial infarction (MI) and persisted 9 months after 
complete coronary artery ligation.  Furthermore, nestin(+) cardiac myocyte-like cells 
were also detected in the infarcted human heart.  Hypoxia represents a predominant 
stimulus following MI, however the exposure of normal rats to a hypoxic 
environment failed to promote the re-appearance of nestin(+) cardiac myocyte-like 
cells.  By contrast, the infusion of the non-selective β-adrenergic agonist 
isoproterenol (ISO) in the normal adult Sprague-Dawley rat increased nestin 
expression in the left ventricle and was associated with the reappearance of nestin(+) 
cardiac myocyte-like cells.  However, the reappearance of nestin(+) cardiac 
myocyte-like cells may not represent a direct effect but was apparently secondary to 
cardiac myocyte necrosis mediated by isoproterenol.  Lastly, we identified a 
subpopulation of nestin-immunoreactive cells in the normal rat heart that co-
expressed cardiac progenitor cell markers Nkx-2.5 and GATA-4.  This 
subpopulation of nestin/Nkx-2.5/GATA-4 cells may represent the progenitor pool 
that differentiates to a nestin(+) cardiac myocyte-like cell following an ischemic 
insult. 
 
 iv 
Key words:  nestin, isoproterenol, cardiac myocyte, cardiac progenitor, necrosis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 v 
Résumé 
 
 Nos études ont démontrées que la formation de la cicatrice et la guérison 
sont associées avec l’apparition de cellules de type myocytes cardiaques nestine(+) 
dans la région péri-infarcie.  Présentement, l’étude examine le mécanisme, tel que 
l’hypoxie ou les hormones neuronales, possiblement impliqué dans leur recrutement 
et de dévoiler leur origine cellulaire.  La présence de ces cellules a été détectée dans 
les coeurs infarcies d’une semaine et maintenue après neuf mois suite à une sujétion 
coronaire complète.  Aussi, ces cellules de type myocytes cardiaques nestine(+) ont 
été observées dans le coeur infarci humain.  L’hypoxie représente un événement 
prédominant suite à un infarctus de myocarde, mais l’exposition des rats normaux à 
un environnement hypoxique n’a pas pu promouvoir l’apparition de ces cellules.  
Autrement, l’infusion de l’agoniste β-adrénergique non-sélectif isoprotérénol (ISO) 
dans les rats adultes Sprague-Dawley a augmenté la protéine nestine dans le 
ventricule gauche et a été associé avec la réapparition de cellules de type myocytes 
cardiaques nestine(+).  Cela représente possiblement un effet secondaire suite à la 
nécrose des myocytes cardiaques par l’administration d’isoprotérénol.  
Dernièrement, on a identifié une sous-population de cellules nestine(+) dans le coeur 
normal du rat qui co-exprime les marqueurs de cellules cardiaques progénitrices 
Nkx-2.5 et GATA-4.  Cette sous-population de cellules nestine/Nkx-2.5/GATA-4 
pourrait représenter des substrats cellulaires qui puissent se différentier en cellules 
de type myocytes cardiaques nestine(+) suite à une ischémie. 
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1. Prevalence of Myocardial Infarctions 
 
1.1 Health Risks 
 
Environmental, genetic, and health risk factors can contribute to coronary 
artery disease ultimately leading to myocardial infarction (MI).  The Heart and 
Stroke Foundation of Canada has reported that since 1994-95 there has been a 
steady rise in hospitalization due to heart attack with an estimated annual 
occurrence of 70 000 myocardial infarctions, with approximately 19 000 being fatal 
(Heart and Stroke Foundation of Canada, 2006).  With 60% of Canadians being 
overweight or obese and nearly half of the population being inactive, the chances of 
diminishing heart attacks will be a constant uphill battle in the coming years and 
new tactics must be developed to overcome this rapidly emerging crisis (Heart and 
Stroke Foundation of Canada, 2004; Statistics Canada, 2007).  Preventative 
measures can be undertaken by at-risk individuals as advised by their physician or 
by making personal lifestyle choices.  In a similar fashion, modern medicine has its 
limitations to post-MI treatment via the administration of certain drugs as well as 
preventing damage at the onset of the MI.  However, what if the heart possessed its 
own primitive repair mechanism to decrease the damage caused by this ever-
growing pandemic.  Stem cell research has constantly been addressing the unlimited 
potential that stem cells possess and how if cultivated within the proper conditions 
will be the future of medicine. 
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1.2 Therapeutics 
 
Following a myocardial infarction, several therapeutic and pharmacological 
interventions exist that can limit further worsening of cardiac function and 
maladaptive remodelling.  Nitroglycerin administration is a common prescription 
that has proven beneficial with its vasodilatory effect on the artery that was 
previously occluded.  ACE inhibitors, such as captopril, aid in the treatment of post-
MI patients via peripheral vasodilatation, ventricular unloading, and diminishment 
of ventricular hypertrophy (Sutton et al., 2000).  β-blockers, including carvedilol, 
reduce the onset of post-MI remodelling events (Sutton et al., 2000). 
 
However, what if the potential that lies in stem cells can be harvested, and 
conform them to the dire need at hand.  Many researchers are evaluating whether 
stem cell cultivation is appropriate during gestation or at time of birth, and to store 
these cells aside for future use.  Similarly, which type of drug administration can 
promote the differentiation of these cells into the desired cell type is still under 
intense research and evaluation.  Undoubtedly, the prospective properties of these 
cells cannot be measured and have not fully been determined but still remain a key 
premise for discovery in times to come despite much ethical debate.  This opens up 
a new realm of possibilities and new strategies for therapeutic treatments in post-MI 
patients. 
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2. Myocardial Infarction 
 
2.1 Coronary Occlusion 
 
 A myocardial infarction occurs when the coronary artery is partially or fully 
occluded by an atherosclerotic plaque.  The ensuing events will lead to left 
ventricular remodelling which is governed by several hormonal, genetic, and 
mechanical factors that will overlap and initiate pathophysiological changes in left 
ventricular morphology and function (Sutton et al., 2000). 
 
 
Fig. 1 - Myocardial infarction (http://www.straightfromthedoc.com/50226711/flickr_39524 
1000.jpg). 
 
The aftermath of the arterial occlusion coincides with a lack of oxygen 
supply creating a hypoxic environment in the afflicted cardiac area and the resulting 
death of the local myocyte population.  In addition to the increase in diastolic load 
following an MI, many intracellular cascades will be activated and initiate 
pathophysiological changes ranging from left ventricular dilatation to the onset of 
collagen scar formation (Sutton et al., 2000).  Similarly, the morphology, thickness, 
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and location of the scar will determine the amount of time that ventricular 
remodelling will require to counteract the distending forces with the scar’s tensile 
strength (Sutton et al., 2000).  Subsequently, the drop in pressure will be sensed by 
baroreceptors and lead to the release of angiotensin II (AII), which in turn will 
stimulate the production and secretion of catecholamines to increase inotropy 
and/or chronotropy in the heart via the sympathetic nervous system. 
 
 
 
2.2  Reparative Fibrosis Post-MI 
 
2.2.1  Role of Myofibroblasts 
 
The infarct region refers to the hypoxic area where cellular necrosis has 
occurred and the necrotic cardiac myocyte population is replaced by granular tissue 
that will eventually undergo a cascade of physiological events leading to scar 
formation.  The initial response consists of lymphocyte invasion to the ischemically 
damaged region.  The subsequent release of inflammatory cytokines such as 
transforming growth factor-β (TGF-β) will promote the recruitment of cardiac 
fibroblasts from the non-infarcted left ventricle to the damaged area and initiate the 
differentiation to a myofibroblasts phenotype (Sutton et al., 2000).  Myofibroblasts 
are characterized by the expression of smooth muscle α-actin and secrete higher 
levels of extracellular matrix proteins (e.g. fibronectin and collagen) to rapidly heal 
the ischemically damaged region via the formation of a permanent scar.  This 
response represents an essential physiological mechanism required to heal the 
damaged heart as is denoted as reparative fibrosis. 
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2.3 Post-MI Left Ventricular Remodelling 
 
2.3.1 Hypertrophy 
 
Left ventricular remodelling is also separated into 2 stages, early and late 
remodelling.  Early remodelling focuses on the expansion of the collagen scar while 
late remodelling revolves around the adaptations made by the infarcted portion of 
the left ventricle to compensate for the increase in wall stress (Sutton et al., 2000). 
 
Cardiac fibroblasts are approximately 2/3 of the total cellular population of 
the heart, cardiac myocytes are the remaining 1/3 and occupy the majority of the 
area of the heart (Booz et al., 1995).  Early remodelling refers to an early time 
frame post-MI where myocyte slippage leads to wall thinning and a reduction in the 
contractile area and volume of the left ventricle (Swynghedauw, 1999).  In a study 
by Olivetti, 2 day post-MI rats had 63% myocytes slippage that led to a 20% 
increase in ventricular chamber dilatation, 33% decrease in wall thickness, and a 
40% reduction in small calibre blood vessels in the scar (Olivetti et al., 1990).  This 
subsequent increase in wall stress will potentiate the onset of cardiac hypertrophy 
and thus, late-stage remodelling. 
 
In late remodelling, the pathophysiological and structural alterations 
occurring in the left ventricle due to myocyte death will serve to normalize the 
increase in systolic and diastolic wall stresses by acting as a potent stimulus for 
pathological eccentric cardiac hypertrophy (Sutton et al., 2000).  In eccentric 
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cardiac hypertrophy, sarcomere genesis occurs in series leading to an increase in 
left ventricular chamber volume and is also characterized by a reversion to fetal 
gene expression affecting proteins such as the conversion of myosin α-heavy chain 
to the β-isoform and cardiac α-actin to the skeletal isoform (Schwartz et al., 1986).  
Similarly, there is a small concentric hypertrophic component occurring that will re-
establish some slight wall thickness via parallel sarcomere genesis.  Also, the onset 
of reparative fibrosis in the left ventricle will also help diminish the effects of high 
wall stress. 
 
 
2.3.2 Reactive Fibrosis 
 
In contrast, to the physiological response of reparative fibrosis, an increased 
deposition of collagen was also reported in the non-infarcted left ventricle (NILV) 
and is referred to as reactive fibrosis.  The latter process is pathological and 
ultimately contributes to left ventricular dysfunction.  Several studies support the 
premise that angiotensin II and the sympathetic system may synergistically promote 
cardiac fibroblast proliferation, thereby initiating the reactive fibrotic response. 
 
 
 
2.4 Angiogenesis and Neurogenesis 
 
In the ischemically damaged heart, the compensatory angiogenic response 
represents an integral event that attempts to prevent cardiac myocyte death in the 
ischemic region at risk thereby limiting infarct size.  The intramyocardial injection 
of angiogenic peptides and administration of cellular substrates (e.g. endothelial 
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progenitor cells, bone marrow-derived cells) for de novo blood vessel formation 
have proven in part therapeutically efficient to limit infarct size.  In addition to 
limiting size, angiogenesis contributes to scar thickening thereby ameliorating the 
healing process.  It has been reported that an increase in scar thickness will limit 
infarct expansion and concomitantly reduce left ventricular dilatation, thereby 
improving left ventricular function (Lindsey et al., 2002; Wang et al., 2004). 
 
It has been well established that myocardial infarction promotes sympathetic 
hyperinnervation, and the study by Vracko et al. (1990) was the first to report 
sympathetic fibers innervating the infarct region of the ischemically damaged rat 
heart.  Subsequent studies by Drapeau et al. (2005) and El-Helou et al. (2005) 
confirmed these latter findings and an analogous paradigm was reported in the 
ischemically damaged human and dog heart as sympathetic fibers projecting from 
the left stellate ganglion were detected innervating the heart (Zhang et al., 2001; 
Zhou et al., 2004).  Collectively, these data support the premise that sympathetic 
fiber sprouting and innervation of the damaged region represents a conserved event 
of myocardial healing across a wide range of species.  The local release of nerve 
growth factor (NGF) by the ischemically damaged heart was identified as a possible 
candidate to promote sympathetic fiber sprouting (Matsuda et al., 1998).   
 
 During cutaneous and corneal wound healing, sympathetic fiber sprouting 
and innervation were reported and chemical sympathectomy was shown to impair 
the healing process (Kishimoto et al., 1982; Perez et al., 1987).  The underlying 
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mechanism(s) attributed to the wound healing action of sympathetic fibers includes 
targeting invading myofibroblasts and angiogenesis.  During cutaneous wound 
healing, nerve fibers were detected innervating myofibroblasts and the release of 
NGF was reported to promote myofibroblast proliferation and migration (Lui et al., 
1999).  Moreover, myofibroblasts represent an important source of NGF and acting 
via a paracrine mechanism promotes sympathetic fiber sprouting (Lui et al., 1999; 
Matsuda et al., 1998).  Furthermore, their role in facilitating angiogenesis was 
identified because of the fact that sympathetic fiber denervation in skeletal muscle 
and brown adipose tissue reduced capillary density in response to cold exposure 
(Borisov et al., 2000; Asano et al., 1997).  De novo blood vessel formation in the 
damaged tissue mediated by sympathetic fiber innervation may occur at least in part 
via the angiogenic action of brain-derived neurotrophic factor (BDNF) and NGF 
(Emanueli et al., 2002; Donovan et al., 2000).  Thus, sympathetic fiber innervation 
may play a seminal role in coordinating myofibroblast proliferation and 
angiogenesis to facilitate proper wound healing.  In the ischemically damaged heart, 
data from Vracko et al. (1990), Drapeau et al. (2005), and El-Helou et al. (2005) 
suggests that the sympathetic system may play an analogous role. 
 
 
 
2.5  Recruitment of Nestin(+) Neural Stem Cells 
 
 El-Helou et al. (2005, 2008) was the first to report that scar formation and 
healing was associated with the recruitment of a resident population of nestin-
expressing neural crest-derived neural stem cells from the normal myocardium to 
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the ischemic region.  Nestin is a type VI intermediate filament protein identified as 
a putative marker of neural stem cells and plays a role in various cellular functions 
including cell division and differentiation to axial growth in neurons (Michalczyk et 
al., 2005).  In addition, transient nestin expression during embryonic development 
may serve as a temporary scaffold until replacement by tissue-specific intermediate 
filament proteins (Michalczyk et al., 2005).  Similarly, the re-expression of nestin 
fibers following ischemic injury may further add to its speculative role in cell 
regeneration or remodeling (Michalczyk et al., 2005).  Biologically, a 
subpopulation of neural stem cells isolated from the infarct region have the capacity 
to differentiate to either a vascular or endothelial cell, thereby representing a 
substrate for de novo blood vessel formation (El-Helou et al., 2008).  Furthermore, 
during reparative fibrosis, nestin(+) processes emanating from neural stem cells were 
detected innervating the peri-infarct/infarct region and physically associated with 
newly-formed neurofilament-M (NF-M) immunoreactive sympathetic fibers (El-
Helou et al., 2005, 2008).  These data suggest that an additional biological role of 
neural stem cells consists of promoting sympathetic fiber sprouting and 
subsequently guiding their innervation to the infarct region.  These data are 
moreover clinically relevant as nestin-expressing cells characterized by a refractive 
cell body and numerous processes were also identified in the viable myocardium 
and infarct region of human patients and were morphologically identical to that 
observed in the rat heart (Fig. 2). 
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Fig. 2 - Nestin(+) neural stem cell. 
 
 
 
 
2.6 The Appearance of Nestin(+) Cardiac Myocyte-like Cells 
 
Unexpectedly, El-Helou et al. (2005) detected the presence of cardiac 
myocyte-like cells expressing the intermediate filament protein nestin, localized 
predominantly in the peri-infarct region. This observation was recently confirmed 
by the study of Scobioala et al. (2008), as nestin-immunoreactive cardiac myocyte-
like cells were detected in the peri-infarct/infarct region of the ischemically 
damaged mouse heart.  The findings are clinically relevant as the presence of 
numerous nestin-immunoreactive cardiac myocyte-like cells were also identified in 
the peri-infarct region of an infarcted human heart (El-Helou et al., 2008).  
Additional studies are required to address whether the appearance of these nestin-
immunoreactive cardiac myocyte-like cells represents a transient response to an 
ischemic insult or is a permanent event associated with scar formation and healing 
In Vivo Neural Stem Cells In Vitro Neural Stem Cell 
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fibrosis.  Furthermore, the stimulus implicated in their recruitment and the source of 
these cells remains undefined.  The focus of the present thesis will address these 
aforementioned unresolved issues. 
 
 
 
2.7 Endogenous Cardiac Progenitor Stem Cell Pools 
 
 Previous studies have already shown the multipotency of nestin-expressing 
stem cells by transdifferentiating into endothelial and neuronal phenotypes, thus 
resident nestin(+) stem cell population are potential candidates in cardiac myocyte-
like cell formation  (Wurmser et al., 2004, Amoh et al., 2004, El-Helou et al., 
2005).  In addition to the nestin-immunoreactive neural stem cell population 
identified in the heart (Drapeau et al., 2005; El-Helou et al., 2005), other studies 
have demonstrated the presence of various cardiac progenitor stem cells, including 
GATA-4 and Nkx-2.5 cells, adding to the notion that the heart is not a terminally 
differentiated organ.  Tomita et al. (2005) identified multipotent adult cardiac stem 
cells expressing stem cell antigen-1 (Sca-1) that are capable of differentiating into 
an endothelial and cardiac myocyte phenotype.  Similarly, musashi-1 expressing 
neural crest-derived stem cells are present in the myocardium and can express the 
cardiac progenitor marker GATA-binding protein 4 (GATA-4) (Tomita et al., 
2005).  Muscle enhancement factor 2C (MEF-2C) represents another population of 
cardiac progenitor cells (Tomita et al., 2005).  A small population of bone-derived 
c-kit(+) (hematopoietic stem cell marker) stem cells have been identified in the 
myocardium and are capable of expressing Nkx-2.5 (Beltrami et al., 2003).  It 
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remains to be determined if these cardiac progenitor cells or endogenous nestin(+) 
neural stem cells are implicated in the formation of nestin-immunoreactive cardiac 
myocyte-like cells or other cellular phenotypes. 
 
 
 
2.8 Neurohormones and Peptides Implicated in Post-MI 
Remodelling 
 
 Following an MI, many hemodynamic changes occur that can trigger 
intracellular cascades ranging from sympathetic nervous stimulation to the renin-
angiotensin pathway (Sutton et al., 2000).  The predominant physiological role of 
the sympathetic system following an ischemic insult is to provide inotropic and 
chronotropic support to the damaged heart.  Moreover, the sympathetic system will 
recruit the renin-angiotensin-aldosterone system to maintain mean arterial blood 
pressure (Sutton et al., 2000). Furthermore, both the sympathetic system and 
angiotensin II participate in cardiac hypertrophy (Sutton et al., 2000) and their 
immediate recruitment following an ischemic insult may directly or indirectly 
contribute to the appearance of nestin-immunoreactive cardiac myocyte-like cells in 
the infarcted heart. 
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3. Sympathetic Nervous System 
 
3.1 Isoproterenol 
 
 Isoproterenol, otherwise known as isoprenaline, is a synthetic 
sympathomimetic non-specific β1 and β2 receptor agonist with little affinity for α-
adrenergic receptors (Voet et al. 2004).  Its chemical structure consists of a benzene 
ring with multiple hydroxyl groups and an amino group, whose structure closely 
resembles that of the neurotransmitter and sympathetic agonist epinephrine (Fig. 3). 
 
   
Epinephrine     Isoproterenol 
 
Fig. 3 - The structures of epinephrine and isoproterenol. 
 
Isoproterenol administration represents an established therapeutic approach 
to treat respiratory disease states such as asthma and bronchitis.  In the heart, 
isoproterenol will act on β1 and β2 adrenergic receptors and elevate heart rate.  It 
can exert inotropic and chronotropic effects such as elevated systolic blood pressure 
and vasodilatory effects including decreased diastolic blood pressure.  Furthermore, 
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a high dosage of isoproterenol can create small pockets of necrosis within the 
myocardium or even induce myocardial infarction and arrhythmia. 
 
 
 
3.2 Adrenergic Receptors 
 
 Adrenergic receptors interact with the autonomic nervous system and to its 
composite branches the sympathetic and parasympathetic nervous systems.  These 
systems provide innervation to muscles and organs such as the adrenal glands and 
initiate biochemical processes that help us initiate the fight-or-flight action via the 
production of different endocrine hormones (Vander et al., 2001).  All sympathetic 
pre-synaptic neurons will form a synapse with muscular motor end-plates (post-
synaptic regions) known as the neuromuscular junction.  Upon pre-synaptic 
membrane depolarization via action potential propagation and Na+ entry, vesicles 
containing neurotransmitters will be released within the synapse (Vander et al., 
2001).  These neurohormones will then bind to specific receptors on the motor end-
plates that will initiate Ca2+ entry within the muscle tissue, increase cytosolic Ca2+ 
levels,  and commence the excitation-contraction process. 
 
 The cardiovascular system requires input from the sympathetic and 
parasympathetic nervous system to perform everyday functions.  For example, they 
can influence pacemaker activity or ensure the necessary adaptations of heart rate, 
cardiac muscle contractility, systolic and diastolic pressures during moments of 
extreme stress, panic or exercise.  Similarly, circulating catecholamines are able to 
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act on the heart via  α- and β-adrenergic receptors (βARs) and exert inotropic 
and/or lusitropic effects.  The heart possesses more βARs than α-adrenergic 
receptors (αARs) (Vander et al. 2001). 
 
βARs are G-protein coupled receptors that contain conserved 7 hydrophobic 
transmembrane domains that anchor the receptor to the plasma membrane and have 
a cytoplasmic C-terminus and an extracellular N-terminus (Zheng et al., 2004).  
These receptors are coupled to trimeric G proteins involved in signal transduction.  
There are 2 subtypes of αARs:  α1 and α2 and there are 3 subtypes of βARs:  β1, β2, 
and β3.  However, each of these receptor subtypes have functional variations in the 
cardiovascular system and differ in the signalling cascades they utilize to perform 
their physiological roles.  The main focus will revolve around the β1 and β2 
subtypes and their signalling pathways (Fig. 4). 
 
 
 
 
Fig. 4 - The signalling pathways of the β-adrenergic receptors (Zheng et al., 2004). 
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3.2.1 β1 Adrenergic Receptors 
 
 The β1 adrenergic receptor occupies 70-80% of the total βAR subtypes in 
the human ventricular myocardium (Brodde, 1991).  It maintains 54% and 51% 
structural homology with the β2AR and β3AR respectively (Zheng et al., 2004).  Its 
function in the heart serves to increase cardiac output by elevating heart rate via the 
depolarization of pacemaker cells in the sinoatrial node and heightened myocardial 
contractility in the left ventricle. 
 
Studies on β1AR knockout mice revealed that when administered 
catecholamines, there were no remarkable variations in inotropy or heart rate 
suggesting the prevalent role of the β1 receptor in cardiac regulation (Rohrer et al., 
1996; Zheng et al., 2004).  Clearly, this indicates how each β receptor subtype can 
constitute a different physiological and pathophysiological function from its cousin 
receptors. 
 
In terms of functional role, the β1AR pathway can follow two distinct 
pathways; apoptosis and hypertrophy or contractility and relaxation. 
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3.2.2 β1 Adrenergic Receptor Signalling 
 
Contraction 
 
 The β1AR pathway works via Gsα-coupling.  A guanosine triphosphate 
(GTP) molecule attaches to the receptor’s α-subunit.  In turn, this will cause a 
conformational change that will separate the α-subunit from the βγ-subunit dimer, 
leading the α-subunit to activate adenylyl cyclase (AC) that will convert adenosine 
triphosphate (ATP) to cyclic adenosine monophosphate (cAMP) (Lodish et al., 
2001).  cAMP, acting as a second messenger, will activate protein kinase A (PKA) 
by separating the regulatory domain from the catalytic domain, and initiate a 
cascade of responses that will lead to increased inotropic and chronotropic effects.  
The intrinsic GTPase activity of the α-subunit, converting GTP to GDP, will then 
terminate the signal by dissociating from AC and re-binding to the βγ-subunit dimer 
(Lodish et al. 2001). 
 
 Within the ventricular myocytes, the activated PKA will phosphorylate L-
type Ca2+ channels on the sarcolemma (Zheng et al., 2004), leading to an influx of 
calcium into the myocytes from the T-tubules.  The T-tubules contain vast 
reservoirs of calcium in sacs known as lateral sacs (Vander et al., 2001).  
Furthermore, phospholamban is inhibiting sarcoplasmic reticulum calcium-ATPase 
(SERCA) channels on the sarcoplasmic reticulum (SR) from re-absorbing the 
intracellular calcium.  The high calcium levels inside the cell will again activate the 
ryanodine receptor (a Ca2+-activated Ca2+ channel) on the SR and increase 
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cytoplasmic calcium levels.  This rise in intracellular calcium levels will allow the 
sarcomere to contract and commence the heart’s pumping action. 
 
 Similarly, the rise in intracellular Ca2+ levels can also be regulated by 
Ca2+/calmodulin-dependent protein kinase II (CaMKII) independently of PKA 
(Zheng et al., 2004).  Wang et al. (2004) provides evidence for this notion based on 
data obtained from inhibiting the PKA pathway and observing that it cannot fully 
impede the increase in Ca2+ as well as the contractile response.  Concomitantly, 
blocking CaMKII activity can terminate sustained receptor stimulation (Wang et al., 
2004).  Furthermore, the data suggests that a time-dependent swap from the PKA 
pathway to CaMKII occurs based on tracing cAMP production and noting its 
desensitization following increased CaMKII activity (Hausdorff et al., 1990). 
 
 
 
 
 
Fig. 5 - Calcium regulation in muscular tissue (http://herkules.oulu.fi/isbn9514267214/ 
html/graphic11.png).  This schematic is a representation of the Ca2+ channels implicated in 
calcium influx into the cytoplasm to initiate muscular contraction.  It also displays the 
channels involved in the removal of calcium leading to muscular relaxation. 
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The Sarcomere:  Muscular Contractile Unit 
 
 The cardiac muscle fibers, much like skeletal muscle, are basically 
comprised of several smaller fibers known as myofibrils.  Each myofibril has 
contractile units known as sarcomeres whose organization allows for its organized 
striated appearance.  Each sarcomere is comprised of thick filaments (myosin) and 
thin filaments (actin).  Proteins such as titin and nebulin serve to stabilize and 
maintain the structure of the thick and thin filaments (Vander et al., 2001). 
 
 Each sarcomere is organized into several sections and delineations known as 
bands and lines (Fig. 5).  Firstly there is the Z-line.  The Z-line forms the border 
around each individual sarcomere and distinguishes it from its neighboring 
sarcomeres.  It is where the thin filaments are anchored to the sarcomere at each end 
(Vander et al., 2001).  The I-band refers to area in between the thick filaments of 
one sarcomere and the adjacent one.  This area will decrease in size as the 
sarcomere contracts.  The A-band is the area that myosin thick filaments occupy 
within the sarcomere.  The H-band is the zone where the actin and myosin will 
interact with each other to reduce the length of the sarcomere and allow for 
muscular contraction to occur (Vander et al., 2001).  Finally, the M-line is in the 
center of the H-band and delineates the center of the sarcomere where the coupling 
action between myosin’s crossbridges and actin will occur (Vander et al., 2001). 
 
 The sliding-filament mechanism of the sarcomere will commence as soon as 
there is a calcium influx within the myocyte.  The calcium will bind to troponin C 
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(a subunit of troponin) that will undergo a conformational change that will move 
tropomyosin with the aid of troponin T (Lodish et al., 2001).  Tropomyosin blocks 
the myosin sites on the actin filaments to prevent maintained contractions.  
Similarly, molecules such as PKA, mentioned earlier, will also remove the troponin 
I inhibitory effect on troponin.  An ATP molecule will bind to the myosin head and 
hydrolyze into ADP that will allow it to bind to actin and initiate the sliding 
movement of thick filament over thin filament.  This will cause a shortening of the 
sarcomere unit and muscular contraction to occur.  Once a new ATP molecule binds 
to the myosin it will detach from actin and begin the process anew (Vander et al., 
2001). 
 
 
 
Fig. 6 - The structure of the sarcomere (http://www.blobs.org/science/cells/sarcomere2.gif). 
 
 
 
Relaxation 
 
 Muscular relaxation is simply the removal of the high levels of intracellular 
calcium within the myocyte by the activation of sarcolemmal and SR channels.  
Once an inhibitory agonist binds to the receptor or the GTP molecule is hydrolyzed, 
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it will lead to the eventual re-association of the α-subunit with the βγ-subunit and 
terminate the activity of adenylyl cyclase.  Sodium-calcium exchangers and 
calmodulin-dependent Ca2+ ATPase on the sarcolemma allow for calcium to exit 
the cell.  Calcium re-enters the T-tubules and calcium is re-stored in the lateral sacs.  
Cytosolic calcium can exit also via mitochondrial Ca2+ channels.  Similarly, 
phosphorylation of phospholamban by PKA removes its inhibition on SERCA 
allowing for Ca2+ re-entry into the SR. 
 
Also, the second messenger can be adversely affected to terminate the 
contractile response.  Phopshodiesterases serve to degrade cAMP to 5’-adenosine 
monophosphate (5’-AMP) and halt the activation of PKA’s catalytic domain 
(Lodish et al., 2001). 
 
The end result is that low levels of Ca2+ will impede troponin’s 
conformational change that allows the subsequent binding of the myosin head to 
actin and thus, allow for sarcomeric length increase and relaxation. 
 
 
Apoptosis 
 
 In addition, to the contraction-relaxation effects of adrenergic signalling, β1 
adrenergic stimulation is known to cause apoptosis.  Previous studies have 
discussed the possibility that the cAMP/PKA pathway to be linked to programmed 
cell death (Communal et al., 1998; Iwai-Kanai et al., 1999).  Different types of 
adenylyl cyclase have been overexpressed to observe their potential effects with 
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regards to apoptosis.  Overexpression of type V and type VI adenylate cyclase do 
not corroborate with an increase in apoptotic levels but increased PKA activity 
(Tepe et al., 1999) and increased cardiac contractility (Gao et al., 1999).  However, 
recently the rise in cytoplasmic calcium level that is coupled with an increase in 
myocardial contractility was in fact due to CaMKII and not linked to the PKA 
pathway (Zheng et al., 2004).  CaMKII blockers significantly reduce the onset of 
apoptosis following β1 receptor signalling versus using blockers for PKA (Zhu et 
al., 2003).  Thus, the activity of CaMKII leads to intracellular Ca2+ overload and an 
eventual increased wear and tear on the myocytes and subsequent cellular death. 
 
 During apoptosis, pro-apoptotic proteins such as Bax are activated that will 
bind to the mitochondrial membrane of the cardiac myocyte.  These pro-apoptotic 
factors will polymerize together to form pores or associate with the permeability 
pore complex for subsequent permeabilization of the outer mitochondrial 
membrane.  In contrast, other pro-apoptotic proteins, such as Bad, will bind and 
inhibit anti-apoptotic proteins, such as Bcl-2, from ensuring caspase activation via 
Apaf-1 blockade (Lodish et al., 2001).  Consequently, the ensuing event will result 
in apoptotic factor release from the mitochondria, including cytochrome c, that will 
bind to Apaf-1 leading to the formation of the apoptosome and in turn activate the 
proteolytic enzymes of the caspase family (Lodish et al., 2001). 
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Hypertrophy 
 
 βAR stimulation is capable of inducing ventricular hypertrophy.  Following 
isoproterenol administration, the chronic activation of the βARs leads to the 
upregulation of β-adrenergic receptor kinase-1, which phosphorylates and leads to 
the membrane downregulation of βARs (Iaccarino et al., 1999).  The subsequent 
impairment of β-adrenergic receptor activity may lead to a compensatory 
ventricular hypertrophic response during pressure overload by which the 
mechanism to induce hypertrophy remains unknown (Iaccarino et al., 1999). 
 
 
 
3.2.3 β2 Adrenergic Receptors 
 
The β2 adrenergic receptor occupies about 20-30% of the total βAR subtypes 
in the human ventricular myocardium (Brodde, 1991).  It maintains 54% and 46% 
structural homology with the β1AR and β3AR respectively (Zheng et al., 2004).  Its 
physiological functions are identical to that of the β1 receptor but to a lesser degree 
of intensity most likely due to its lower density presence in the myocardium.  
Evidence for this is shown in β2AR knockout mice following catecholamine 
administration and how a complete cardiac response is elicited (Zheng et al., 2004).  
Similarly, β1AR knockout mice display a lack of this heightened response 
demonstrating how they are not the primary receptors for inotropic and 
chronotropic reactions (Rohrer, et al. 1996; Zheng et al., 2004). 
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3.2.4 β2 Adrenergic Receptor Signalling 
 
Contraction, Relaxation, and Anti-Apoptosis 
 
 Unlike β1ARs that have Gs signalling, β2ARs have dual coupling to Gs and 
Gi (Zheng et al., 2004).  The associated Gi signalling provides a cardioprotective 
effect by reducing the dramatic results of Gs stimulation and promoting cell survival 
(Zheng et al., 2004).  For instance, β2AR Gi signalling activates the Na+/Ca2+ 
exchanger on the sarcolemma leading to Ca2+ unloading in the sarcoplasmic 
reticulum (Sato et al., 2004).  However, it exerts its anti-apoptotic effects by 
coupling to the PI3K-Akt pathway and not through MAPKs (Chesley et al., 2000; 
Zheng et al., 2004). 
 
The Gs signalling remains identical to β1AR via the classic adenylyl cyclase-
cAMP-PKA pathway leading to a subsequent rise in intracellular Ca2+ levels, 
though not as elevated as through β1AR regulation to induce myocardial 
contraction.  The relaxation signalling process remains the same as that for β1AR. 
 
The anti-apoptotic effects of β2 stimulation are Gi-dependent following in 
vitro β2AR blocking (Communal et al., 1999).  The cardioprotective Gi pathway 
commences with the activation of phosphotidylinositol-3-kinase (PI3K) (Fig 6).  
Whether it is Giα- or Giβγ-coupled, it remains unclear.  PI3K will in turn 
phosphorylate phosphatidylinositol-2-phosphate (PIP2) and convert it to 
phosphatidylinositol-3-phosphate (PIP3).  PIP3 activates Akt (or protein kinase B) 
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via phosphorylation, which will phosphorylate and inactivate apoptotic factors such 
as Bad and ensure cell survival (Chang et al., 2003).  Inhibiting the Gi-PI3K-Akt 
pathway results in β2AR stimulation switching to promote apoptosis (Zhu et al., 
2001). 
 
 
 
Fig. 7 - The anti-apoptotic pathway of β2AR stimulation via the PI3K-Akt pathway (Chang 
et al., 2003). 
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 Scar formation and healing is essential to heal the ischemically damaged 
heart and involves the interplay of numerous physiological events including 
inflammation, myofibroblast deposition of collagen, angiogenesis, and sympathetic 
fiber innervation mediated by cardiac neural stem cells.  Work from Calderone’s 
group revealed the novel observation that following ischemic injury to the rat, the 
peri-infarct/infarct region contained an abundance of nestin-immunoreactive cardiac 
myocyte-like cells (El-Helou et al., 2005, 2008).  An analogous paradigm was 
reported in the infarcted human heart.  Thus, the primary objective of the present 
thesis is to identify the phenotype and origin of nestin-immunoreactive cardiac 
myocyte-like cells and the stimuli implicated in the expression. 
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Experimental Models 
 
Human MI Tissue 
 
 The use of human cardiac tissue was approved by the Clinical Ethics board 
of the Montreal Heart Institute.  Cardiac tissue samples (non-infarcted left ventricle 
and infarct region) were obtained from patients (3 males, 1 female; range 30-83 
years old) who died either 1 week (n = 2) or 3 months (n = 2) following myocardial 
infarction.  These samples were previously used in the study by El-Helou et al. 
(2008). 
 
 
MI Rat Model 
 
 In this experimental model, we are creating a myocardial infarction in the rat 
by ligating the left anterior descending coronary artery and then allowing the rat to 
survive for a specific period of time post-MI ranging from 1 week to 9 months.  
Male Sprague Dawley rats (Charles River) weighing approximately 200-250 g were 
under initial anaesthesia using 3% isofluorane, followed by a reduction to 1.5% 
during the ligating procedure.  Following the post-MI survival period, the hearts 
were excised and stored in either 2-methylbutane to perform immunofluorescence, 
frozen in liquid nitrogen for use in molecular biology experimentation, or in 
formalin for immunohistochemistry.  The use and care of laboratory animals was 
according to the Canadian Council for Animal Care and all animal studies were 
approved by the Animal Care Ethics Committee of the Montreal Heart Institute. 
 
 31 
Hypoxia Rat Model 
 
 Male Sprague-Dawley rats (200-250 g; Charles River) were placed in a 
Plexiglas chamber (width 63 cm; height 43 cm; depth 60 cm) into which a 
continuous flow of air and pure nitrogen mixture was delivered, resulting in an 
inspired oxygen fraction (FiO2) of 0.12.  The flow rates of the gases were controlled 
using individual flow meters, and the FiO2 was confirmed using an oxygen analyzer 
(Applied Electrochemistry model S-3A/I).  Exposure to continuous hypoxia was 
maintained for 10 days and then the rats immediately sacrificed.  The sham rats 
were maintained in ambient air.  The hearts of all animals were subsequently stored 
in 2-methylbutane. 
 
 
Isoproterenol Infusion Rat Model 
 
 Male Sprague-Dawley rats (200-250 g; Charles River) were implanted 
(intraperitonially) with osmostic pumps (model 2ML1, 10 µL/hr; Alzet) containing 
either isoproterenol (infusion rate; 30 mg/kg/day) or saline for a period of 1 week.  
Rats were subsequently sacrificed, the hearts excised and stored in either 2-
methylbutane to perform immunofluorescence or frozen in liquid nitrogen for 
protein/mRNA experiments. 
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Hemodynamic Measurements 
 
 The rats were anaesthetized using a mixture of ketamine (50 mg/kg) and 
xylazine (10 mg/kg).  The lead electrodes were inserted in the left and right arms, 
and the left leg to measure and establish Einthoven’s triangle to provide the 
electrocardiogram to view the electrical activity of the heart.  The EMKA 1.8.11.12 
program also provided a measure of the heart rate by the addition of the QR or 
measuring the systolic pressure curves. 
 
Carotid catheter insertion method was used to measure the arterial pressure 
and the left ventricular pressure.  Similarly, a jugular catheter insertion measured 
the right ventricular pressure.  The method also calculated the rate of contraction 
(dP/dT), based on the steepest point of the ascending pressure curve, and the rate of 
relaxation based on the steepest point of the descending pressure curve.  The 
diastolic pressure is represented by the smallest pressure reading of the pressure 
curve.  The end-diastolic pressure is the point when the slope begins to rise and the 
systolic pressure is the highest peak point of the curve. 
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Cultured Neonatal Rat Cardiac Myocytes and Exposure to Hypoxia 
 
 Hearts were removed from 1-3 day old neonatal Sprague-Dawley rats 
anesthetized with ether and killed by decapitation. Ventricular tissues were placed 
immediately in chilled Ca2+-free HBSS (GIBCO) and digested with 0.1% trypsin 
(GIBCO) in HBSS overnight at 4 oC.  Ventricular cells were subsequently 
recovered by repeated digestions in 10 mL of 0.1% collagenase type II (GIBCO).  
The supernatants collected from each digestion were centrifuged and re-suspended 
in ice cold HBSS, followed by another centrifugation and re-suspension in DMEM 
containing 7% heat-inactivated FBS (GIBCO).  The cells were preplated twice in 
T75 flasks (VWR) to enrich for myocytes and decrease contamination by 
nonmuscle cells.  The non-adherent myocytes were then plated (100 mm plate; 
VWR) at a density of 100-200 cells per mm2 for protein and mRNA studies.  After 
24 hours, the culture medium was changed to serum-free DMEM containing ITS (5 
µg/ml insulin, 5 µg/ml transferrin, 5 ng/mL sodium selenite; GIBCO); all 
experiments were performed 24 hours later. 
 
 Neonatal rat ventricular myocytes were placed in a humidified chamber (In 
Vivo 400 Work Stations) maintained at 37 oC.  An oxygen sensor constantly 
monitored the atmosphere and ensured hypoxic conditions by maintaining the 
oxygen level at 1%.  Myocytes were exposed to a hypoxic environment for either 8 
or 24 hour periods and nestin protein and mRNA levels were assessed.  As a 
positive control, VEGF mRNA expression was determined.  The normoxic 
environment consisted of 5% CO2 and 21% O2 at 37 oC. 
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Biochemistry Techniques 
 
Protein Extraction 
 
 Cardiac tissue or cell cultures were lysed in a buffer containing 10 mM Tris 
(pH 7.5), 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 50 mM, NaF, 0.5 mM PMSF 
(0.174 g/10 mL in ethanol), 1 mM sodium vanadate, 1% Triton X-100, 0.5% Igepal 
CA-630, 1 µg/mL of aprotinin (1 mg/mL in H2O), and 1 µg/mL of leupeptin (1 
mg/mL in DMSO).  The tissue sample was placed in a 50 mL tube containing 2-3 
mL of the lysis buffer.  The tissue was grinded using the Polytron and the samples 
settled on ice for 1 hour.  The homogenate samples were centrifuged at 10 000 
RPM for 10 minutes at 4 oC.  The supernatant was collected and stored at -20 oC.  
The protein concentration was measured using the Bradford assay technique. 
 
Western Mini-Gel Electrophoresis, Transfer, and Blot 
 
 The results from the Bradford assay technique were used to calculate and 
load a protein sample 100 µg in weight.  Acetone precipitation concentrated low 
concentration lysates into pellets followed by dissolution in 10 µL SBJ 1X.  
Concentrated samples were directly mixed with SBJ 2X for 25 µL loading volume.  
The SBJ contained 1 M Tris (pH 6.8), 30% glycerol, 6% SDS, 15% β-
mercaptoethanol, and bromophenol blue.  Prior to loading, the samples were then 
heated at 70 oC for 1-2 minutes to allow protein denaturation. 
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 The lysates were subjected to SDS-polyacrylamide gel (10-15%) 
electrophoresis and protein subsequently transferred to a PVDF membrane.  
Immunoblotting was performed using 5% skim milk or BSA for 1-2 hours followed 
by successive PBS-Tween washings.  The primary antibody was added and 
incubated at 4 oC overnight.  The antibodies employed include mouse monoclonal 
anti-nestin (1:500; Millipore), mouse monoclonal anti-GAPDH (1:1000000; 
Ambion), mouse monoclonal anti-smooth muscle α-actin (1:2000; Sigma), mouse 
monoclonal anti-Bax and anti-Bcl-2 (1:500; Santa Cruz Biotechnology).  Following 
overnight incubation at 4 oC, goat anti-mouse conjugated to horseradish peroxidase 
(1:10000, Santa Cruz Biotechnology) was added and visualization of the bands 
were detected by autoradiography utilizing the ECL detection kit (PerkinElmer Life 
Science). 
 
 
Immunofluorescence 
 
The rat heart was excised, immediately immersed in 2-methylbutane and 
stored at -80 oC.  Primary passage neonatal rat ventricular myocytes were fixed with 
4% paraformaldehyde prior to staining.  Tissues were sectioned at 14 µm using the 
cryostat and placed on poly-lysine coated slides and fixed with 4% 
paraformaldehyde (pH 7.2).  Fixed cells or tissue were permeabilized with 2% 
normal goat serum (NGS) and 0.5% Triton X-100 for 1-2 hours at room 
temperature, and subsequently incubated overnight at 4oC with the appropriate 
antibody diluted in 1% NGS and 0.1% Triton X-100.  Antibodies employed include 
mouse monoclonal anti-nestin (1:500; Millipore), rabbit polyclonal anti-desmin 
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(1:600; Abcam), rabbit polyclonal anti-NFM (1:500; Millipore) rabbit polyclonal 
anti-β1-adrenergic receptor, anti-Nkx-2.5, anti-GATA-4, and anti-connexin-43 
(Santa Cruz Biotechnology).  Following incubation, fixed tissue or cells were 
incubated for 1-2 hours at room temperature with either goat anti-mouse IgG 
conjugated to Alexa Fluor 555 (1:600; Invitrogen; emission wavelength at 570 nm) 
or goat anti-rabbit IgG conjugated to Alexa Fluor 488 (1:800; Invitrogen; emission 
wavelength at 520 nm) diluted in 0.05-0.1% Triton X-100 in PBS containing 1% 
NGS.  To stain the nucleus, cells or tissue were initially treated with RNase (100 
µg/µL; MBI Fermentas) for 20 minutes at 37 oC and then incubated for 20 minutes 
at room temperature with the fluorescent label to-pro3 (Invitrogen; 1.5 µM; 
emission wavelength 661 nm).  Non-specific staining was determined following the 
addition of either an isotype control antibody (mouse IgG, 5 µg/mL; rabbit IgG, 17 
µg/mL) or the secondary antibody alone.  The concentration of each isotype control 
was equivalent to the highest concentration of antibody employed.  The slides were 
mounted on a 1:4 mixture of DABCO and glycerol prior to confocal microscope 
visualization.  Immunofluorescence staining was visualized with either 10X- or 
63X-oil 1.4 NA DIC plan apochromat objective mounted on a Zeiss Axiovert 100M 
confocal microscope. 
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Molecular Biology Techniques 
 
Real-Time Polymerase Chain Reaction (Real Time-PCR) 
 
 Total RNA was isolated from the control and treated samples of cell cultures 
and/or ISO-treated adult rat hearts by a modification of the guanidine 
isothiocyanate-phenol-chloroform method.  A cDNA library was generated by 
incubating 5 ng/µL total RNA (each sample), M-MLV reverse transcriptase (800 U, 
Invitrogen), RNaseOUT (40 U, Invitrogen), random-hexamer primers (0.04 U, 
Amersham Biosciences), dNTPs (0.5 mmol/L, MBI Fermentas), and supplied 
optimal buffers.  The reaction protocol consisted of 3 successive incubation steps at 
(1) 25 oC for 10 minutes, (2) 37 oC for 50 minutes, and (3) 70 oC for 15 minutes. 
 
 Real-time polymerase chain reaction (PCR) was performed on 2.5 ng of 
cDNA template containing the appropriate primers (300 nmol/L) and SYBR Green 
PCR master mix (Applied BioSystems).  Primers for each gene were obtained from 
distinct exons that spanned an intron by using the Ensembl Genome Browser 
program (http://www.ensembl.org).  The sequence specificity of each primer was 
verified with the Blast program derived from the National Center for Biotechnology 
Information (http://www.ncbi.nlm.nih.gov).  The primers used were as follows:  for 
rat β-actin, forward 5’-AGGCTCTCTTCCAGCCTTCC-3’ and reverse 5’-CATGG-
ATGCCACAGGATTCC-3’; for rat nestin, forward 5’-TGCAGGCCACTGATAA-
GTTCCA-3’ and reverse 5’-TTCTCCTGCTCCAGGGCTTCCA-3’; for rat 
collagen type I, forward 5’-CTGACGCATGGCCAAGAAGACA-3’ and reverse 
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5’-CGTGCCATTGTGGCAGATACAGAT-3’; for rat GATA-4, forward 5’-ATG-
GGCACAGCAGCTCCA-3’ and reverse 5’-CATGGCCGGACACAGTACTG-3’; 
for rat MEF-2C, forward 5’-GCCATCTGCCCTCAGTCAGT-3’ and reverse 5’-
TGAGATAAATGAGTGCTAGTGCAAGC-3’; for rat Nkx-2.5, forward 5’-CAA-
GGACCCTCGGGCG-3’ and reverse 5’-TTTGTCCAGCTCCACCGC-3’; and for 
rat VEGF-A, forward 5’-GAAATCCCGGTTTAAATCCTGG-3’ and reverse 5’-
CGCTCTGAACAAGGCTCACAG-3’.  Appropriate negative controls were used 
for each experiment. 
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Statistics 
 
 Data were presented as means ± SE, where n represents the number of rats 
used in each experiment.  Morphological and hemodynamic results were evaluated 
by a bilateral Student’s unpaired T-test.  Protein and mRNA expression were 
evaluated with a 1-way ANOVA and a significant difference was detected using the 
Neuman-Keuls post hoc test.  A value of P < 0.05 is considered statistically 
significant. 
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1. The phenotype and presence of neural stem cells and nestin-
immunoreactive cardiac myocyte-like cells in the infarcted 
rat and human heart. 
 
 In the normal rat heart, nestin immunoreactivity was detected exclusively in 
the neural stem cell population, marked by a refractive cell body and numerous 
processes, intercalated among terminally-differentiated connexin-43(+) cardiac 
myocytes (Fig. 1).  Neural stem cells did not stain positive for connexin-43, a gap 
junctional protein and marker of adult cardiac myocytes, whereas nestin was not 
expressed in adult cardiac myocytes.  Following ischemic damage, neural stem cells 
were observed in the non-infarcted (Fig. 2A) and peri-infarct region (Fig. 2B) of the 
3-week post-MI rats.  Moreover, bordering the scar, structurally and 
morphologically immature nestin-immunoreactive cardiac myocyte-like cells were 
detected and expressed the cardiac specific marker desmin (Fig. 2B).  Similarly, a 
rarity of nestin-immunoreactive cardiac myocyte-like cells has also been identified 
in the non-infarcted region (Fig. 2A).  The underlying mechanisms attributed to 
their appearance remain presently undefined. The latter paradigm was not a 
transient response as nestin-immunoreactive cardiac myocyte-like cells (Fig. 3A, 
3B & 3C) were detected in the peri-infarct/infarct region of 9-month post-MI rats.  
In contrast to the phenotype of cardiac myocytes residing in the viable myocardium 
(Fig. 4A), immunoreactivity of the gap junctional protein connexin-43 implicated in 
action potential propagation was either absent, lateralized or in the cytoplasm of 
nestin-immunoreactive cardiac myocyte-like cells (Fig. 4B).  Phenotypically, these 
data demonstrate that structural and morphological immaturity nestin-
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immunoreactive cardiac myocyte-like cells may represent a substrate for 
arrhthymogenesis (Rucker-Martin et al., 2006). 
 
 In the human infarcted heart, nestin-expressing cells were identified in the 
viable myocardium and scar and exhibited an identical anatomical phenotype to the 
population of neural stem cells residing in the infarcted rat heart (Fig. 6A & 6B).   
Concomitantly, structurally and morphologically immature nestin-immunoreactive 
cardiac myocyte-like cells were also detected in the infarcted human heart of 1-
week post-MI patients (Fig. 6B) followed by a robust increase and maintenance of 
this cellular phenotype following 3 months post-MI (Fig. 6C & 6D).  Furthermore, 
desmin immunoreactivity was detected in nestin-immunoreactive cardiac myocyte-
like cells (Fig. 5A, 5B, 5C, & 5D).  Lastly, akin to that reported in the rat infarcted 
heart, connexin-43 immunoreactivity was either absent, lateralized or in the 
cytoplasm of structurally and morphologically immature nestin-immunoreactive 
cardiac myocyte-like cells in the infarcted human heart (Fig. 6B, 6C, & 6D). 
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Fig. 1 - The absence of nestin-immunoreactive cardiac myocyte-like cells in the 
normal rat heart.  Nestin immunoreactivity (red fluorescence) was detected in 
nestin(+) neural stem cells (denoted by arrows) intercalated between nestin(-) cardiac 
myocytes (denoted by *) that stained positive for the gap junctional protein 
connexin-43 (Cx43) (green fluorescence).  The nucleus was identified with the blue 
fluorescent marker to-pro3. 
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Fig. 2 - The presence of structurally and morphologically immature nestin(+) 
cardiac myocyte-like cells in 3-week post-MI adult rats.  A:  Possible terminally 
differentiated nestin (red fluorescence) and desmin-immunoreactive (green 
fluorescence) cardiac myocyte-like cell (denoted by *) in the non-infarcted left 
ventricle with nestin(+) neural stem cells (denoted by arrows).  The underlying 
mechanisms attributed to its appearance remain undefined.  B:  Presence of 
structurally and morphologically immature nestin(+)/desmin(+) cardiac myocyte-like 
cell in the peri-infarct region surrounded by nestin(+) neural stem cells.  The nucleus 
was identified with the blue fluorescent marker to-pro3. 
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Fig. 3 - The presence of structurally and morphologically immature nestin(+) 
cardiac myocyte-like cells in 9-month post-MI adult rats.  A:  Nestin(+) (red 
fluorescence) and desmin(+) (green fluorescence) cardiac myocyte-like cell (denoted 
by *) observed after 9 months in the peri-infarct region reflects a non-transient 
response.  B:  Presence of structurally and morphologically immature 
nestin(+)/desmin(+) (green fluorescence) cardiac myocyte-like cell in the infarct 
region.  C:  Nestin(+)/desmin(+) cardiac myocyte-like cells detected in the peri-infarct 
region.  The nucleus was identified with the blue fluorescent marker to-pro3. 
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Fig. 4 - Connexin-43 organization in the heart of sham and 1-week post-MI 
rats.  A:  Cx43 (green fluorescence) is highly organized in the normal myocardium.  
Nestin(+) (red fluorescence) neural stem cells (denoted by arrows) are present in the 
heart.  B:  An aberrant pattern of Cx43 staining, either lateralized or cytoplasmic, 
was detected in nestin(+) cardiac myocyte-like cells (denoted by *).  The nucleus 
was identified with the blue fluorescent marker to-pro3. 
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Fig. 5 - The presence of structurally and morphologically immature 
nestin(+)/desmin(+) cardiac myocyte-like cells in the infarcted human heart.  A:  
Nestin(+) (red fluorescence) cardiac myocyte-like cell (denoted by *) in the infarct 
region.  The same phenotypical myocyte-like cell was also observed in the infarcted 
rat heart.  B: Desmin(+) (green fluorescence) immunoreactivity of the same 
myocyte-like cell.  C:  Nestin and desmin co-localization.  D:  Structurally and 
morphologically immature nestin(+)/desmin(+) cardiac myocyte-like cell forming in 
the scar.  The nucleus was identified with the blue fluorescent marker to-pro3. 
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Fig. 6 - The presence of nestin(+) cardiac myocyte-like cells in the infarcted 
human heart.  A:  Presence of nestin(+) neural stem cells (red fluorescence) 
intercalated between cardiac myocytes in the viable myocardium of a 3 month post-
MI patient.  B:  In 1 week post-MI, presence of nestin(+) neural stem cells (denoted 
by arrows) and nestin(+) cardiac myocyte-like cells (denoted by *) with aberrant 
connexin-43 (green fluorescence) staining.  C:  in 3 months post-MI, presence of 
nestin(+)/Cx43(+) cardiac myocyte-like cells in the peri-infarct.  D:  In 3 month post-
MI, nestin(+)/Cx43(+) cardiac myocyte-like cell (denoted by *) in the peri-infarct 
with Cx43 lateralization.  The nucleus was identified with the blue fluorescent 
marker to-pro3. 
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2. Exposure of rat cardiac myocytes to hypoxia does not 
promote nestin expression. 
 
 Unresolved issues include the source of nestin-immunoreactive cardiac 
myocyte-like cells and the stimulus implicated.  The peri-infarct/infarct region 
represents a hypoxic environment (Wang et al., 2005) and it is tempting to speculate 
that hypoxia alone may induce the expression of nestin in surviving cardiac 
myocytes residing in this region.  Therefore, the following experiments tested the 
hypothesis that nestin protein is induced in cardiac myocytes following exposure to 
hypoxia.  The exposure of adult male Sprague-Dawley rats to normobaric hypoxia 
(12% O2) for a period of 10 days failed to promote nestin expression in terminally 
differentiated cardiac myocytes (Fig. 7 & 8) and did not further lead to an increased 
expression in neural stem cells (Fig. 9B), as compared to rats exposed to ambient 
air (21% O2) (Fig. 9A).  Alternatively, it is possible that exposure of the rat to 12% 
O2 did not adequately reflect the hypoxic milieu of the peri-infarct/infarct region.  
To circumvent this issue, isolated rat ventricular myocytes were exposed to 1% O2 
(normobaric hypoxia) for either 8 or 24 hours.  Employing an immunofluorescence 
approach, nestin expression was not detected in connexin-43 immunoreactive rat 
ventricular myocytes (Fig. 10).  By contrast, nestin immunoreactivity was detected 
in isolated cardiac neural stem cells.  Furthermore, nestin mRNA expression was 
not increased in hypoxic rat ventricular myocytes (Fig. 11B), whereas VEGF 
mRNA levels were significantly elevated (P < 0.05) in neonatal ventricular 
myocytes following either an 8 (3.2±0.5-fold) or 24 hour (5.1±0.9-fold) exposure to 
hypoxia (Fig. 11A).  Thus, collectively, these data suggest that hypoxia alone 
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cannot promote the reappearance of nestin-immunoreactive cardiac myocyte-like 
cells and cardiac myocytes do not represent the source of these cells in the 
myocardial infarcted rat heart. 
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Fig. 7 - Nestin expression in the left and right ventricles of normoxic and 
hypoxic rats.  In the hypoxic rats (n = 2), no significant change was detected in 
nestin expression in comparison to normoxic rats (n = 2).  Nestin protein levels 
were normalized to GAPDH protein content. 
 
 
 
 
 
Fig. 8 - Quantitative analysis of nestin protein expression in normoxic and 
hypoxic rats.  Nestin  protein did not significantly increase in the left ventricle of 
the ISO-treated group (n = 2).  Data are represented as fold increase vs. control 
group (n = 2).  *P < 0.05 vs. control group.  Data were evaluated by a 1-way 
ANOVA, and a significant difference was determined by Neuman-Keuls post hoc 
test. 
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Fig. 9 - Nestin(+) cardiac myocyte-like cells undetected in the myocardium 
following hypoxia.  A:  presence of nestin(+) (red fluorescence) neural stem cells 
(denoted by arrows) in normoxic adult rats with connexin-43 (green fluorescence) 
identifying normal cardiac myocytes.  B:  continued presence of nestin(+) neural 
stem cells in hypoxic adult rats with absence of nestin(+) cardiac myocyte-like cells.  
The nucleus was identified with the blue fluorescent marker to-pro3. 
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Fig. 10 - Nestin immunoreactivity (red fluorescence) not detected in Cx43(+) 
(green fluorescence) neonatal ventricular cardiac myocytes following both 
normoxic and hypoxic exposures.  The cells were exposed to 0, 8, and 24 hrs 
hypoxia treatment and nestin expression was not observed.  The nucleus was 
identified with the blue fluorescent marker to-pro3. 
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Fig. 11 - Effect of hypoxic exposure on neonatal cardiac myocytes.  A:   Nestin 
mRNA expression after hypoxia in neonatal cardiac myocytes.  Employing real-
time PCR, nestin mRNA was unchanged after hypoxia, whereas VEGF-A mRNA 
was significantly increased (n = 4) P < 0.05 (denoted by *) versus sham.  Data were 
presented as the mean S.E.M, (n) represented independent preparations of neonatal 
cardiac myocytes, and mRNA levels normalized to β-actin mRNA.  B:  Nestin 
protein expression in neonatal cardiac myocytes.  Nestin fluorescence was not 
detected after hypoxia whereas fluorescent phalloidin (red fluorescence), marking 
actin filaments, was observed. 
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3. Nestin-expressing cells in the normal rat heart express 
markers of cardiac progenitor cells. 
 
 The hypoxic experiments support the premise that hypoxia alone is 
insufficient to promote nestin expression in rat cardiac myocytes.  Alternatively, 
hypoxia may be implicated but the absence of nestin protein induction in cardiac 
myocytes in response to a hypoxic stimulus in vivo or in vitro suggests that nestin-
immunoreactive cardiac myocyte-like cells may originate from an alternative 
myocardial-derived population of cells.  As a first step to address this issue, we 
examine whether a subpopulation of nestin-immunoreactive cells in the normal rat 
heart were associated with expression of markers associated with cardiac progenitor 
cells.  First, mRNA expression of established markers of cardiac progenitor cells 
including, GATA-4, Nkx-2.5, and MEF-2C were detected in the normal adult rat 
heart (Fig. 12).  GATA-4 staining was identified in the nucleus and cytoplasm of 
terminally differentiated cardiac myocytes, whereas Nkx-2.5 staining was not 
detected.  Second, GATA-4 and Nkx-2.5 staining was detected in the cytoplasm of 
nestin-expressing cells in the normal rat heart (Fig. 13A & 13B).  However, these 
transcriptional factors were not detected in the entire population, thereby 
demonstrating that at least two populations of nestin-expressing cells exist 
identified by the absence or presence of Nkx-2.5/GATA-4 (Fig. 13A & 13B).  
Furthermore, we also identified GATA-4/Nkx-2.5 immunoreactive cells that did not 
express nestin and detected intercalated among cardiac myocytes and the signal was 
detected predominantly in the cytoplasm (Fig. 13A & 13B).  Thus, at least two 
populations of cells expressing markers of cardiac progenitor cells exist in the 
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normal rat heart distinguished by the absence or presence of nestin.  These findings 
indirectly suggest that either population or both may be the source of nestin-
immunoreactive cardiac myocyte-like cells following ischemic damage. 
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Fig. 12 - Cardiac progenitor cell marker expression in normal adult rat hearts.  
GATA-4, Nkx-2.5, and MEF-C expression were detected in sham group (n = 5) of 
rats. 
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Fig. 13 - Distinguished subpopulations of nestin and cardiac progenitor stem 
cells are intercalated in between cardiac myocytes in the normal heart.  A:  
nestin(+) (red fluorescence) neural stem cells with a subpopulation of GATA-4(+) 
(green fluorescence) cardiac progenitor cells (denoted by white arrows).  In 
contrast, nestin(+)/GATA-4(+) (denoted by blue arrows) cells have also been 
observed.  B:  Nestin(+)/Nkx-2.5(+) (green fluorescence) (denoted by blue arrows) 
cells are detected in the normal heart with sparse Nkx-2.5(+) cells (denoted by white 
arrows).  The nucleus was identified with the blue fluorescent marker to-pro3. 
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4. β1-adrenergic receptor staining was detected in nestin-
expressing cells. 
 
 Sympathetic hyperinnervation represents a common feature following 
myocardial infarction and our lab has demonstrated sympathetic fiber sprouting in 
the peri-infarct/infarct region of the ischemically damaged rat heart.  These findings 
provided the impetus to assess whether the sympathetic system may contribute in 
part to the appearance of nestin-immunoreactive cardiac myocyte-like cells 
following myocardial infarction in the rat heart.  Consistent with this premise, β1-
adrenergic receptor immunoreactivity was ubiquitously detected in nestin-
expressing cells residing in the normal rat heart (Fig. 14A & 14B).  Thus, the 
population of nestin-expressing cells that express Nkx-2.5/GATA-4 represent a 
target of the sympathetic system.  Therefore, these latter findings provided the 
impetus for the following experiment to examine whether isoproterenol infusion via 
osmotic pump implantation can promote the appearance of nestin-immunoreactive 
cardiac myocyte-like cells.  Isoproterenol infusion significantly increased cardiac 
weight and the rate of left ventricular contraction and relaxation as compared to 
saline-infused rats (Table 1 & 2).  Additional sham and ISO-treated rat hearts were 
utilized for hemodynamic measurements prior to usage for immunofluorescence 
and Sirius Red immunohistological staining.  Furthermore, nestin protein 
expression was significantly increased in the heart of isoproterenol-treated rats 
compared to saline-treated rats (Fig. 16 & 17).  Employing an immunofluorescence 
approach, structurally and morphologically immature nestin- and β1AR-
immunoreactive cardiac myocyte-like cells were identified in the heart of 
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isoproterenol-treated rats (Fig. 14C, 14D, 15A, 15B, 15C, & 15D).  However, the 
preponderance of structurally and morphologically immature nestin-
immunoreactive cardiac myocyte-like cells was detected in close proximity to or 
within localized regions of apparent tissue death.  Consistent with these findings, 
the apoptotic protein Bax and anti-apoptotic protein Bcl-2 significantly increased in 
the heart of isoproterenol-treated rats (Fig. 16 & 17).  Furthermore, extensive 
fibrosis was detected throughout the left ventricle following isoproterenol 
administration using Sirius Red immunohistological staining (Fig. 18B) as a 6-fold 
increase in collagen content was detected as compared to sham rats (Fig. 18A). 
Consistent with these data, left ventricular collagen α1 type 1 mRNA expression 
was significantly increased as compared to sham rats (Fig. 19). 
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Fig. 14 - β1-adrenergic receptor (β1AR) immunoreactivity in nestin(+) stem cells 
and nestin(+) cardiac myocyte-like cells.  A:  nestin (red fluorescence) depicting 
the nestin(+) stem cell population.  B:  cytoplasmic β1AR (green fluorescence) 
immunoreactivity in the nestin(+) stem cells (denoted by arrows) and β1AR 
immunoreactivity was also observed on the plasma membrane of cardiac myocytes 
(denoted by *).  C:  appearance of nestin(+) cardiac myocyte-like cell.  D:  
membrane and nuclear expression of β1ARs in nestin(+) cardiac myocyte-like cells.  
The nucleus was identified with the blue fluorescent marker to-pro3. 
 
 
 
 
 
 
 
A 
C 
B 
D 
sham sham 
ISO ISO 
* * 
 62 
 
 
 
Fig. 15 - Numerous nestin(+) cardiac myocyte-like cells expressing β1-
adrenergic receptors (β1ARs) in ISO-treated rats.   A, B, C, D:  the nestin(+) 
cardiac myocyte-like cells (denoted by *) following ISO-delivery are maintaining 
β1AR expression while the neighboring normal cardiac myocytes have 
downregulated their β1AR expression. 
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Table 1.  Body and heart weights of sham and 1-week ISO-treated rats 
 
  BW, g      Heart, g  LV, mg  LV/BW, mg/g  RV, mg  RV/BW, mg/g 
 
Sham (n = 6)  364 ± 7  1130 ± 38 538 ± 20  1.48 ± 0.05 175 ± 8  0.48 ± 0.02 
ISO (n = 5)  350 ± 11  1455 ± 100** 665 ± 40* 1.89 ± 0.06*** 234 ± 18* 0.67 ± 0.05** 
 
Data are presented as means ± SE; n = no. of rats examined.  ISO, isoproterenol; BW, body weight; LV, left ventricle; RV, right 
ventricle.  *P < 0.05 vs. sham.  **P < 0.01 vs. sham.  ***P < 0.001 vs. sham.  Data were evaluated and a significant difference was 
determined by Student’s unpaired T-test. 
 
 
 
Table 2.  Hemodynamic parameters of sham and 1-week ISO-treated rats 
 
   LVSP, mmHg  LVEDP, mmHg  LV +dP/dt, mmHg/s LV-dP/dt, mmHg/s 
 
Sham (n = 12)          153 ± 9         11 ± 1      7048 ± 253        6036 ± 311 
ISO (n = 10)      153 ± 9         17 ± 2*      9072 ± 453***        7275 ± 518* 
 
Data are presented as means ± SE; n = no. of rats examined.  ISO, isoproterenol; LVSP, left ventricular systolic pressure; LVEDP, left 
ventricular end-diastolic pressure; LV +dP/dt, rate of LV contraction; LV –dP/dt, rate of LV relaxation.  *P < 0.05 vs. sham.  ***P < 
0.001 vs. sham.  Data were evaluated and a significant difference was determined by Student’s unpaired T-test. 
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Fig. 16 - Smooth muscle α-actin, Bax, Bcl-2, and nestin expression in the left 
ventricle of sham and ISO-treated rats.  In the ISO-treated rats, smooth muscle 
α-actin, Bax, Bcl-2, and nestin increased significantly in the left ventricle following 
isoproterenol administration compared to sham rats.  SMα-actin, Bax, Bcl-2 and 
nestin protein levels were normalized to GAPDH protein content. 
 
 
 
 
Fig. 17 - Quantitative analysis of protein expression in the left ventricle of 
sham and isoproterenol-treated rats.  Smooth muscle α-actin, nestin, Bax, and 
Bcl-2 protein were significantly increased in the left ventricle of the ISO-treated 
group (n = 5).  The increase in Bax confirms the onset of apoptosis in the ISO-
treated group, followed by concurrent fibrotic response substantiated by the rise in 
SMA.  Data are represented as fold increase vs. sham group (n = 6).  *P < 0.05 vs. 
sham group.  Data were evaluated by a 1-way ANOVA, and a significant difference 
was determined by Neuman-Keuls post hoc test. 
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Fig. 18 - Sirius Red immunohistological staining of collagen in the left ventricle 
of sham and ISO-treated rats.  A:  No visible signs of fibrosis detected in the 
myocardium of sham rats.  B:  Extensive fibrosis in the heart of ISO-treated rats as 
reflected by increased collagen deposition.  
 
 
 
 
 
 
 
Fig. 19 - Collagen mRNA expression in the left ventricle of sham and 
isoproterenol-treated rats.  Collagen α1 type 1 mRNA increased significantly, 
thus indicative of the onset of fibrosis in the left ventricle of ISO-treated rats (n = 4) 
compared to sham rats (n = 6).  Data are represented as fold increase vs. sham rats.  
*P < 0.05 vs. sham rats.  Data were evaluated by a 1-way ANOVA, and significant 
difference was determined by the Neuman-Keuls post hoc test.
sham 
A 
ISO 
B 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DISCUSSION 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 67 
 Scar formation following ischemic damage to the heart represents an 
essential physiological response and is denoted as reparative fibrosis (El-Helou et 
al., 2005).  The biological events associated with reparative fibrosis include 
inflammation, the differentiation of a fibroblast to a myofibroblast and subsequent 
deposition of collagen, and angiogenesis (Frangogiannis NG, 2008).  Work from 
Calderone’s group and others have recently demonstrated that sympathetic fiber 
sprouting and innervation of the peri-infarct/infarct region represents a conserved 
event of healing in the ischemically damaged heart (Vracko et al., 1990; Zhang et 
al., 2001; Drapeau et al., 2005; Zhou et al., 2004; El-Helou et al., 2005).  The 
postulated biological role of the sympathetic system during reparative fibrosis may 
involve coordinating angiogenesis and myofibroblast proliferation. Lastly, 
Calderone’s group made the novel observation that the rat heart contained a resident 
population of neural stem cells that migrated to the infarct region following 
ischemic injury (Drapeau et al., 2005).  In the infarct region, a subpopulation of 
these neural stem cells may represent a novel cellular substrate for de novo blood 
vessel formation, thereby contributing to the intrinsic angiogenic response in the 
scar (El-Helou et al., 2008).  During the latter studies, an unexpected observation 
was the appearance of nestin-immunoreactive cardiac myocyte-like cells bordering 
the infarct region.  These nestin-immunoreactive cardiac myocyte-like cells were 
structurally and morphologically immature as compared to terminally differentiated 
cardiac myocytes and appeared to be in a state of differentiation.  These findings 
indirectly supported the basis of a plausible intrinsic self-regeneration capacity of 
the heart where new cardiac myocytes are identified by nestin expression.  In the 
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normal rat heart and viable myocardium of an MI rat heart, cardiac myocytes do not 
express nestin.  These observations were recently reaffirmed by Scobioala et al. 
(2008), as nestin-immunoreactive cardiac myocyte-like cells were detected in the 
peri-infarct region of the infarcted mouse heart.  Lastly, these nestin-
immunoreactive cardiac myocyte-like cells were also identified in the infarcted 
human heart (Mokry et al., 2008; El-Helou et al., 2008).  Thus, these data have 
provided the impetus to examine the phenotype and origin of these nestin-
immunoreactive cardiac myocyte-like cells and identify the stimuli implicated in 
their appearance. 
 
 The appearance of structurally and morphologically immature nestin-
immunoreactive cardiac myocyte-like cells during the early phase of scar formation 
in the rat heart was not a transient response, as these cells were identified 9 months 
post-MI.  Concomitantly, these nestin-immunoreactive cardiac myocyte cells were 
also detected in the peri-infarct/infarct regions of the ischemically damaged human 
heart and were detected at least 3 months after myocardial infarction.  These data 
suggest that the persistent presence of nestin-immunoreactive cardiac myocyte-like 
cells may represent an important aspect in scar healing.  However, the biological 
role of these cells in reparative fibrosis remains presently undefined.  Furthermore, 
the co-expression of the intermediate filament desmin, connexin-43, and the 
emergence of a striated phenotype reaffirmed the premise that these nestin-
immunoreactive cardiac myocyte-like cells reflected a cardiac myocyte phenotype.  
However, the staining pattern of connexin-43, a cardiac myocyte gap junctional 
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protein implicated in action potential propagation, was aberrant.  In either the 
normal rat heart or the viable myocardium of an infarcted rat heart, connexin-43 
immunoreactivity was detected intercalated at gap junctions between cardiac 
myocytes.  By contrast, in structurally and morphologically immature nestin-
immunoreactive cardiac myocyte-like cells, connexin-43 staining was absent, in the 
cytoplasm or lateralized.  A similar paradigm was also observed in nestin-
immunoreactive cardiac myocyte-like cells identified in the infarcted human heart.  
The aberrant pattern of connexin-43 expression in this subpopulation of cells 
bordering the peri-infarct may represent an underlying mechanism attributed to the 
reported arrythmogenesis following myocardial infarction (Amino et al., 2006).  
Furthermore, a recent study by Rucker-Martin et al. (2006), reported that connexin-
43 lateralization on cardiac myocytes may represent an important contributor to the 
genesis of arrythmias.  Thus, the aberrant pattern of connexin-43 in a subpopulation 
of cardiac myocyte-like cells that selectively express nestin may represent a novel 
substrate contributing to arrythmogenesis and sudden cardiac death following 
ischemic damage. 
 
 It has been well established that the peri-infarct/infarct region is a hypoxic 
environment secondary to an inadequate angiogenic response (Lee et al., 2000).  
During the early phase of scar formation, structurally and morphologically 
immature nestin-immunoreactive cardiac myocyte-like cells were identified 
predominantly in the peri-infarct/infarct region.  These observations provided the 
impetus to suggest that the hypoxic environment of the peri-infarct/infarct region 
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may have initiated the induction of nestin in surviving cardiac myocytes.  To 
directly test this premise, normal male adult Sprague-Dawley rats were exposed to 
normobaric hypoxia (12% O2) for 10 days whereas the sham group was exposed to 
ambient air (21% O2).  The exposure of rats to hypoxia failed to promote the 
reappearance of nestin-immunoreactive cardiac myocyte-like cells.  Furthermore, 
nestin protein content in the heart of hypoxic rats was similar to sham further 
suggesting that hypoxia did not influence the resident cardiac neural stem cell 
population.  Thus, these data suggest that a hypoxic environment was insufficient to 
initiate the appearance of nestin-immunoreactive cardiac myocyte-like cells.  
Alternatively, it is possible that a hypoxic environment of 12% O2 was not 
comparable to that of the infarct region and therefore, inadequate to promote nestin 
expression in cardiac myocytes.  To resolve the latter issue, neonatal rat ventricular 
myocytes were exposed to 1% O2 and despite a near anoxic environment, neither 
nestin protein nor mRNA were expressed.  However, as a positive control, VEGF 
mRNA levels were significantly increased, as the promoter region of the gene 
contains the hypoxia response element (HRE) (Breen et al., 2008).  Collectively, 
these data support the premise that the exposure to hypoxia alone was insufficient to 
promote the reappearance of nestin-immunoreactive cardiac myocyte-like cells in 
the adult rat heart or isolated neonatal rat ventricular myocytes.  Furthermore, 
cardiac myocytes did not appear to represent the cellular source of nestin-
immunoreactive cardiac myocyte-like cells.  In this regard, an alternative 
myocardial-derived population of cells recruited following an ischemic insult may 
differentiate to a nestin-immunoreactive cardiac myocyte-like cell. 
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 The work from Anversa’s group identified a population of cardiac 
progenitor cells that expressed the transcriptional factors Nkx-2.5 and GATA-4 
(Beltrami et al., 2003).  These transcriptional factors were reported to contribute to 
cardiac myocyte differentiation during development (Jamali et al., 2001).  However, 
these studies failed to examine whether these Nkx-2.5/GATA-4 cardiac progenitor 
cells express nestin.  Furthermore, it remains unknown if the population of nestin-
immunoreactive cardiac myocyte-like cells that were identified in the infarcted rat 
or human heart initially expressed nestin and subsequently differentiated to a 
cardiac myocyte-like cell or if nestin was induced during differentiation.  Thus, as a 
first approach, we examined if a subpopulation of nestin-expressing cells in the 
normal rat heart expressed the cardiac progenitor markers Nkx-2.5/GATA-4.  
Indeed, Nkx-2.5 and GATA-4 immunoreactivity was identified in a subpopulation 
of nestin-expressing cells that resembled anatomically the neural stem cell 
population.  However, nestin-immunoreactive neural stem cells were also identified 
that lacked Nkx-2.5/GATA-4 staining.  Therefore, these data suggest that the heart 
contains at least two populations of nestin-expressing cells distinguished by the 
absence or presence of Nkx-2.5/GATA-4.  It remains presently unknown if either 
population may represent the source of nestin-immunoreactive cardiac myocyte-like 
cells.  Interestingly, the study by Tomita et al. (2005), likewise identified a nestin 
population of cells in the mouse heart that exhibited characteristics of a neural stem 
cell.  Furthermore, the injection of these mouse-derived nestin-expressing cells in 
the heart differentiated to a cardiac myocyte.  In this regard, these latter data 
indirectly suggest that nestin-expressing cells that contain Nkx-2.5/GATA-4 may 
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indeed be recruited following ischemic damage and differentiate to a cardiac 
myocyte-like cell.  Lastly, we also identified Nkx-2.5/GATA-4 cells intercalated 
among cardiac myocytes in the normal rat heart that lacked nestin expression.  In 
our studies, we did not examine if the latter population expressed c-kit, an 
additional marker of cardiac progenitor cells reported by Anversa’s group (Beltrami 
et al., 2003).  However, it is also possible that these nestin-negative Nkx-
2.5/GATA-4 cells may be recruited following an ischemic insult and during 
differentiation to a cardiac myocyte-like cell expresses nestin. 
 
 Work from Calderone’s group and others have demonstrated that newly 
formed sympathetic fibers innervate the peri-infarct/infarct region and may play a 
seminal role in scar healing (Vracko et al., 1990; Zhang et al., 2001; Drapeau et al., 
2005; Zhou et al., 2004; El-Helou et al., 2005).  Thus, based on the latter findings 
and the presence of nestin-immunoreactive cardiac myocyte-like cells in the peri-
infarct/infarct region, we tested the hypothesis that sympathetic system may be 
involved in their reappearance following an ischemic insult.  In support of this 
premise, β1-adrenergic receptor staining was detected ubiquitously in the nestin-
immunoreactive neural stem cell population.  Therefore, nestin-immunoreactive 
neural stem cells that express Nkx-2.5/GATA-4 may represent a target of the 
sympathetic system.  The infusion of the non-selective β-adrenergic agonist 
isoproterenol in the normal male adult rat heart significantly increased cardiac 
weight, heart rate, and contractility.  Furthermore, nestin protein expression was 
significantly increased in isoproterenol-treated rats compared to vehicle-treated rats.  
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Employing an immunofluorescence approach, the global presence of nestin-
immunoreactive cardiac myocyte-like cells was not observed in the heart of 
isoproterenol-treated rats.  By contrast, a paucity of nestin-immunoreactive cells 
was detected in regions associated with tissue loss.  The latter finding is not 
unexpected as several studies have reported the apoptotic action of β-adrenergic 
agonists on cardiac myocytes (Krishnamurthy et al., 2007; Menon et al., 2006).  
Indeed, consistent with these findings, the apoptotic protein Bax and the anti-
apoptotic protein Bcl-2 were significantly increased in the heart of isoproterenol-
treated rats.  Furthermore, extensive fibrosis was detected throughout the 
myocardium following isoproterenol administration and confirmed by the 
significant increase of left ventricular collagen content.  Collectively, these data 
suggest that the appearance of nestin- and β1AR-immunoreactive cardiac myocyte-
like cells represents a compensatory response to the loss of cardiac myocytes 
initiated by isoproterenol-mediated cardiac myocyte apoptosis.  In addition, in our 
opinion, the significant increase of nestin protein expression in isoproterenol-treated 
rats was not secondary to the paucity of nestin-immunoreactive cardiac myocyte-
like cells detected in these hearts.  By contrast, the increase expression of nestin 
may be directly related to β-adrenergic-mediated neural stem cell proliferation.  
Lastly, β1-adrenergic receptor immunoreactivity was markedly reduced in adult 
cardiac myocytes following isoproterenol treatment and was consistent with the 
premise of G-protein coupled receptor downregulation following chronic agonist 
exposure (Karoor et al., 1996).  By contrast, β1-adrenergic receptor expression 
remained persistent in nestin-immunoreactive cardiac myocyte-like cells and neural 
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stem cells.  The underlying mechanism(s) associated with the refractive nature of 
these cells to maintain β1-adrenergic receptor following isoproterenol treatment 
remains presently unknown.  However, the expression of the β1-adrenergic receptor 
coupled to aberrant connexin-43 immunoreactivity in these phenotypically 
immature nestin-immunoreactive cardiac myocyte-like cells further corroborates the 
arrythmogenic premise of the cells as in the infarcted heart model. 
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 Our study is the first to demonstrate the appearance of nestin(+) cardiac 
myocyte-like cells bordering the infarct region of both rat and human infarcted 
hearts.  Their reappearance is not a transient response since nestin(+) cardiac 
myocyte-like cells were detected in 3- and 9-month post-MI human and rat hearts, 
respectively.  Aberrant connexin-43 staining coupled to the presence of the β1-
adrenergic receptor in these nestin(+) cardiac myocyte-like cells suggests that this 
subpopulation of cells may represent a novel substrate for arrhythmogenesis 
following an ischemic insult.  The exposure of either the rat or isolated ventricular 
myocytes to hypoxia failed to stimulate nestin expression in terminally 
differentiated cardiac myocytes.  Therefore, these data suggest that nestin(+) cardiac 
myocyte-like cells may originate from a resident cardiac progenitor stem cell pool.  
Indeed, we detected a subpopulation of nestin-expressing cells in the normal rat 
heart that expressed the cardiac progenitor markers Nkx-2.5 and GATA-4.  
Therefore, it is possible that the reappearance of nestin(+) cardiac myocyte-like cells 
following ischemic injury may be derived at least in part from nestin/Nkx-
2.5/GATA-4 immunoreactive cells.  An important issue that was not addressed in 
the present thesis is the biological role of these nestin(+) cardiac myocyte-like cells.  
Our prevailing hypothesis is that the reappearance of these nestin(+) cardiac 
myocyte-like cells represents an adaptive physiological response that attempts to 
replace the lost population of cardiac myocytes following myocardial infarction.  
Therefore, identifying stimuli implicated in the reappearance of nestin(+) cardiac 
myocyte-like cells may represent a potential therapeutic approach to limit infarct 
expansion following an ischemic insult. 
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